Responding to Doubts, Slapping Faces On The Spot

"Mr. Wei, please answer me. Are these data real or fake?"

The question exploded beside everyone's ears like a clap of thunder.

Everyone stared at Dr. Schmitz in shock, momentarily frozen.

He was actually publicly questioning the authenticity of the clinical trial report at the press conference. He had come looking for a fight.

Well, well. Since he could not refute the drug's efficacy, he was going straight for the jugular and accusing them of fraud.

For the domestic anti-cancer drug market, was he willing to stop at nothing and tear off all pretense?

The representatives of the domestic pharmaceutical companies were both embarrassed and furious. They had initially found the New Anti-Cancer Drug's effects far too good to be believable themselves.

But Dr. Schmitz's arrogant interrogation, his contempt and suspicion toward domestic pharmaceutical companies, felt like a huge slap striking every one of them across the face. It instantly stirred a sense of shared outrage in them.

Even General Manager Wu of New Beauty looked grim at that moment, his heart filled with anger. He had seen this kind of arrogance and prejudice often enough when dealing with foreign giants. Now, seeing Three Purities being questioned, he could not help but empathize. It was as if every question was interrogating his own soul.

He clenched his fists and thought darkly, You little bastard, you'd better not have falsified anything. If you really lied and get exposed by these foreigners, disgracing every domestic pharmaceutical company, I'll never let you off.

The media representatives did not look pleased either. At first, they had been ecstatic, thinking they had stumbled upon explosive news.

But they quickly came to their senses and were angered by Schmitz's accusations.

What, Chinese pharmaceutical companies could not develop effective anti-cancer drugs?

Why should they assume Three Purities had faked its data?

The other international pharmaceutical giants, meanwhile, all wore gloating smiles.

Although they too were shocked by Schmitz's blunt accusation, he had indeed voiced what they were thinking.

They had come in skeptical to begin with, and after seeing the clinical data, they simply refused to believe it.

Pharmaceutical companies around the world invested tens of billions every year into R&D, yet this obscure little Chinese pharmaceutical company had somehow developed such a miracle drug.

It was simply unbelievable. This had to be fake.

That was what they thought, but since they did not yet have a direct competitive conflict, there was no need to tear off all pretense like Merck had.

Thus, only the representative from Roche Pharmaceuticals nodded in agreement.

Everyone else wore curious expressions, eager to watch the drama unfold.

So everyone looked to Wei Kang with immense anticipation, waiting to see how he would answer the accusation.

Wei Kang was naturally not intimidated in the slightest.

He gave a cold laugh and shot back sharply.

"Dr. Schmitz, let me ask you this: is Merck's drug development capability the best in the world? Can it represent the highest level of the global pharmaceutical industry?"

"As far as I know, the world's number-one pharmaceutical company is not Merck. Moreover, your strength in anti-cancer drugs is not particularly impressive. You only have one flagship product, Keytruda. When it comes to developing targeted anti-cancer drugs and immunotherapies, your record is rather lacking."

Wei Kang's words angered Dr. Schmitz.

"Are you questioning my authority?"

"Young man, Merck is indeed not the world's number-one pharmaceutical company, and we do indeed have only one flagship anti-cancer product, Keytruda. But we have always persisted in researching anti-cancer drugs."

"We have worked in the field of anti-cancer drugs for decades. The R&D funds we invest every year are beyond anything you Chinese can imagine. Last year, Merck's oncology business generated 15.8 billion US dollars in revenue, but our R&D investment was also the highest among all pharmaceutical giants, reaching 13.5 billion US dollars."

"I believe annual R&D spending of more than ten billion can prove something."

"The funds we invest exceed what all the pharmaceutical companies in your country combined can match, and even vastly surpass the market value of many of your pharmaceutical companies."

"Mr. Wei, I would like to ask: how much does your company invest in R&D every year?"

Wei Kang nodded. "You have a point. So what you mean is that whoever spends more on drug development will succeed, while whoever spends less definitely cannot?"

"I recall news reports saying that Merck spends billions of US dollars every year purchasing new drug formulas from other laboratories, and even acquires many other small pharmaceutical companies. Is that true?"

"Since you are so wealthy and invest more than ten billion US dollars, why have you not developed a second Keytruda? Why have you not developed any other targeted drugs?"

"With all that money, why have you not developed the new drugs that those small pharmaceutical companies can develop?"

Dr. Schmitz was immediately at a loss for words. For a moment, he could not find anything to say in rebuttal.

After all, this industry only looked at results, not empty talk.

No matter how eloquently you spoke or how much money you claimed to have invested, without results, it meant nothing.

This young man was sharp-tongued indeed. He would not be easy to deal with!

But Dr. Schmitz would not back down. He had to force the other side completely into a corner, leaving him no chance to recover.

After all, Merck's oncology business accounted for 40% of its pharmaceutical revenue, and more than 95% of that revenue came from Keytruda. It could be said that Merck's oncology business rested entirely on Keytruda, making it extremely risky. If a broad-spectrum anti-tumor drug with miraculous efficacy were to suddenly emerge and completely replace Keytruda, it would be the company's nightmare.

In China's anti-cancer drug market, Merck's pharmaceutical business revenue in China was 3.534 billion US dollars, up 13% year-on-year, making it Merck's best-performing market worldwide.

The global oncology market had already reached 150 billion US dollars and had maintained rapid growth of 15% over the past five years. It was expected to break through the 200 billion US dollar mark within the next few years. China accounted for less than 10% of that market, and its share of the overall drug market was also relatively low. It was still in the early stages of development, with vast room for future growth.

No pharmaceutical giant would give up the immensely lucrative piece of meat that was the Chinese market, with its limitless potential.

So Dr. Schmitz brought out his trump card.

"Mr. Wei, clinical trial data can be falsified. How can you prove that all these data are real?"

Wei Kang smiled faintly. Heh heh, I've been waiting for you to say that.

Did you think I would come to this press conference unprepared, to face you arrogant foreign bastards?

He stated firmly, "This clinical data report is absolutely real. I can guarantee it."

"Moreover, I have evidence here."

He opened his laptop and displayed new materials on the screen.

"These are case files from some patients at Kun City First People's Hospital. You can clearly see the before-and-after comparison of patients taking our new drug. These are blood test reports, CT scans, and ultrasound scans, as well as surgical and treatment records for some patients, along with photos from before and after their illness."

"We obtained the consent of one hundred patients in total. They were willing to share their case files as evidence, so everyone could see just how miraculous this drug's effects are."

"Any one of you may come and review the case materials of these one hundred patients. However, for the sake of patient privacy, they may only be viewed here and cannot be taken away."

"For any drug, all data on paper is pale and unconvincing. Only the patients' treatment results are the most direct and genuine evidence. Only the recovery of patients can prove a drug's success."

"So, take a good look at just how successful our New Anti-Cancer Drug truly is!"

"If you still cling to your prejudice and refuse to believe the real data and case files I have provided, then you can wait until this drug hits the market and let it slap you in the face."

"I'll be waiting to see that!"

At that moment, a female doctor in a white coat suddenly stood up from the audience and declared loudly, "I am an oncologist at Kun City First People's Hospital, and I can guarantee the authenticity of these case files."

Several more doctors in white coats immediately stood up beside her, some old and some young. They were all her colleagues. Everyone nodded in unison, solemnly stated their identities, and offered their guarantees.

Dr. Schmitz's face flushed red. After stammering for quite some time, he finally said, "Then the side effects in your report are so minor. That is absolutely impossible!"

Wei Kang snorted coldly and looked at him. "Oh? Keytruda has severe side effects, so you think the anti-cancer drug we developed must also have especially severe side effects?"

He suddenly smiled. "Let me think. What side effects does Keytruda have?"

"Hmm, it seems it really does have quite a lot of side effects." Wei Kang gave a Heh heh laugh and smoothly rattled off a passage he had prepared long ago.

"Keytruda's major adverse reactions include edema, dizziness, diarrhea, nausea, numbness, shortness of breath, muscle pain, cognitive impairment, coughing, vomiting, fever, joint pain, and visual abnormalities."

"The most severe adverse reactions include congestive heart failure, central nervous system reactions—such as cognitive impairment, anxiety, depression, even suicidal thoughts, dizziness or loss of balance, insomnia or excessive sleep—fractures, liver toxicity, hyperuricemia, QT interval prolongation, and visual abnormalities."

After reciting it, he sneered. "Is your drug meant to save people or kill them?"

"Dr. Schmitz, just because you cannot accomplish something does not mean we cannot."

"After so many years of development and revitalization, our country's pharmaceutical industry has become highly advanced. I would not dare say we have surpassed the world's top pharmaceutical companies, but in certain areas, we have already reached an internationally leading level."

"General Manager Wu of Xinmei Pharmaceutical Group should have plenty to say on that matter."

"As far as I know, Xinmei Group recently developed an Anti-Cancer Injection for lymphoma. It can cure patients in two months and has no serious side effects either. General Manager Wu, am I right?"

General Manager Wu had been listening intently from below when Wei Kang suddenly called on him, leaving him momentarily stunned.

Once he came to his senses, pride filled his heart. He straightened his chest and raised his head. "That's right. Xinmei also has formidable research and development capabilities in targeted anti-cancer drugs. At the very least, in targeted drugs, we are no worse than Merck. Ha ha."

He glanced at Andre from Pfizer and smiled. "Moreover, Xinmei has recently entered into a partnership with Pfizer to build a targeted anti-cancer drug portfolio together. Mr. Andre, am I correct?"

Andre hesitated for a moment before lightly nodding.

Dr. Schmitz's face turned stark white. Without saying a word, he sat down.

The media reporters were all stunned. Why had all these people from the pharmaceutical companies gone silent?

Could it be that the clinical trial report was real, and everything Wei Kang had said had already been confirmed?

They soon grew excited.

Wow, huge news! At its new drug launch, Sanqing Pharmaceutical faced provocation from international pharmaceutical giants and slapped them in the face on the spot!

President Wei Kang faced questions from a global authority in oncology and, after a fierce verbal exchange, left the other party utterly speechless!

At the same time, he decisively presented evidence, defended his own reputation, and greatly boosted the prestige of our country's pharmaceutical industry!

Once this was reported, it would become another shocking headline and a patriotic news story that set the public ablaze.

Sanqing's New Anti-Cancer Drug was truly a delightful surprise. This new anti-cancer drug had a 100% efficacy rate and zero side effects.

It was bound to replace the anti-cancer drugs of other pharmaceutical companies and become the most popular, as well as the most legendary, miracle drug of the coming decades.